Plasminogen activator inhibitor antagonists
US6677473B1 · kind B1 · utility
79Cited by
88References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 17, 2000 |
| Grant date | Jan 13, 2004 |
| Priority date | — |
| Expiry date | Dec 16, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C65/24
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds and pharmaceutical compositions useful as plasminogen activator inhibitor (PAI) antagonists are provided. In particular, methods of antagonizing PAI with substituted and unsubstituted aryl and heteroaryl ethers and thioethers, benzils, benzyl ethers, benzoate esters, sulfones and benzophenones are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.